Beranda › Penyakit Paru Interstisial › Colorado › Denver
Uji klinis Penyakit Paru Interstisial di Denver, CO
6 studi untuk Penyakit Paru Interstisial mencari peserta di lokasi sekitar Denver (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaFase 2
- University of Colorado, Denver
- National Jewish Hospital, Denver
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Menerima pesertaFase 2
- National Jewish Health, Denver
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Menerima peserta
- National Jewish Health, Denver
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Menerima pesertaFase 3
- National Jewish Hospital, Denver
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaStudi observasional
- National Jewish Health, Denver
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Menerima pesertaStudi observasional
- National Jewish Health, Denver
Uji klinis Penyakit Paru Interstisial di kota lain
- New York City, NY18 studi
- Philadelphia, PA16 studi
- Los Angeles, CA14 studi
- Kansas City, KS13 studi
- Durham, NC13 studi
- Charleston, SC13 studi
- Chicago, IL12 studi
- Houston, TX12 studi
- Ann Arbor, MI11 studi
- Aurora, CO11 studi
- Phoenix, AZ9 studi
- Salt Lake City, UT9 studi
Studi lain di Denver
- Kanker Metastatik29 studi
- Kanker Payudara28 studi
- Mieloma Multipel27 studi
- Kanker Paru Non-Sel Kecil27 studi
- Kanker Kolorektal23 studi
- Kanker Prostat19 studi
- Melanoma19 studi
- Kanker (semua jenis)18 studi
- Kanker Ovarium16 studi
- Kanker Paru16 studi
- Kanker Endometrium15 studi
- Limfoma Non-Hodgkin14 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.